- Home
- JSPR vs VATE Comparison
JSPR vs VATE Comparison
Compare JSPR & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- VATE
- Stock Information
- Founded
- JSPR 2018
- VATE 1994
- Country
- JSPR United States
- VATE United States
- Employees
- JSPR N/A
- VATE N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- VATE Metal Fabrications
- Sector
- JSPR Health Care
- VATE Industrials
- Exchange
- JSPR Nasdaq
- VATE Nasdaq
- Market Cap
- JSPR 85.8M
- VATE 98.2M
- IPO Year
- JSPR N/A
- VATE 1996
- Fundamental
- Price
- JSPR $5.82
- VATE $5.25
- Analyst Decision
- JSPR Strong Buy
- VATE
- Analyst Count
- JSPR 10
- VATE 0
- Target Price
- JSPR $62.22
- VATE N/A
- AVG Volume (30 Days)
- JSPR 367.9K
- VATE 19.8K
- Earning Date
- JSPR 08-12-2025
- VATE 08-06-2025
- Dividend Yield
- JSPR N/A
- VATE N/A
- EPS Growth
- JSPR N/A
- VATE N/A
- EPS
- JSPR N/A
- VATE N/A
- Revenue
- JSPR N/A
- VATE $1,066,100,000.00
- Revenue This Year
- JSPR N/A
- VATE N/A
- Revenue Next Year
- JSPR N/A
- VATE N/A
- P/E Ratio
- JSPR N/A
- VATE N/A
- Revenue Growth
- JSPR N/A
- VATE N/A
- 52 Week Low
- JSPR $3.13
- VATE $3.25
- 52 Week High
- JSPR $26.05
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- JSPR 53.78
- VATE 42.89
- Support Level
- JSPR $5.35
- VATE $5.04
- Resistance Level
- JSPR $5.91
- VATE $5.37
- Average True Range (ATR)
- JSPR 0.43
- VATE 0.22
- MACD
- JSPR -0.02
- VATE 0.02
- Stochastic Oscillator
- JSPR 64.41
- VATE 33.87
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.